PET-CT exams can diagnose 'cognitive reserve' in early-onset AD

A recent study revealed that the "cognitive reserve" in early-onset Alzheimer's disease (AD) and PET-CT examinations can be used to effectively to identify early-onset AD patients.

"Although early-onset Alzheimer's dementia is quite rare, it can be devastating to the patients that carry the diagnosis," said Dr. Jacob Richard Hodge, lead researcher for this study at the Mayo Clinic in Rochester, Minn. "Symptoms are often unexpected and support networks are generally directed towards an older population."

In patients presenting with similar clinical severities of the disease, researchers for this study discovered a "cognitive reserve," which slowed the outward expression of symptoms. "Our research demonstrates that those patients with increasing education are better able to cope with the disease pathology before they express the symptoms of Alzheimer's dementia," Dr. Hodge said. This study evaluated PET-CT examinations in 91patients under age 65 to see if this cognitive reserve could be identified with early-onset AD, which often has a more aggressive course and progression.

Additionally, researchers replicated previously published data using PET-CT examinations, and they were able to detect significant abnormalities in patients with early-onset AD, thereby supporting its usefulness with younger patients. "Alzheimer's dementia is often not suspected in younger patients," Dr. Hodge said. "Therefore, PET-CT brain imaging can be helpful in the diagnosis."

While the discovery of the "cognitive reserve" will not slow the progression of the disease, Hodge is confident that patients can improve the quality of their lives with the proper diagnosis and education. "Once the diagnosis is determined, a patient can begin to manage the disease and plan for the future," Dr. Hodge stated.

Dr. Hodge will deliver a presentation on this study on Monday, May 2, 2011 at the 2011 ARRS Annual Meeting at the Hyatt Regency Chicago.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Update on diagnosis, risk classification and treatment of Kawasaki Disease